Figure 1: Subject disposition. AE, Adverse Event; c/mL, copies/milliliter; CW, Consent Withdrawal; D/C, Discontinued; LPV/r, Lopinavir/ritonavir; LFU, Lost to Follow-Up; NRTI, Nucleoside Reverse Transcriptase Inhibitor; PD, Protocol Deviation; TDF, Tenofovir Disoproxyl Fumarate; VL, Viral Load (HIV-1 RNA).